Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome

NCT06898372 · clinicaltrials.gov ↗

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Aicardi-Goutières Syndrome (AGS)

Interventions

DRUG: JAK Inhibitor

Sponsor

IRCCS Fondazione Stella Maris